Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study

BackgroundIndividuals with schizophrenia have substantially elevated cardiovascular morbidity and mortality, a disparity further exacerbated by coexisting type 2 diabetes mellitus (T2DM). The impact of specific antipsychotics on long-term cardiovascular outcomes in patients with T2DM remains unclear...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Yi-Ting Yeh, Shih-Chang Lo, Chien-Ning Huang, Yi-Sun Yang, Pei-Lun Liao, Edy Kornelius
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Subjects:	aripiprazole risperidone MACE schizophrenia diabetes
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1617534/full